Goodrx Holdings Inc
NASDAQ:GDRX

Watchlist Manager
Goodrx Holdings Inc Logo
Goodrx Holdings Inc
NASDAQ:GDRX
Watchlist
Price: 4.935 USD 5.22%
Market Cap: 1.8B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
-41%
Revenue
Forecast
0%
Operating Income
Forecast
N/A
Net Income
Forecast
+79%

Wall Street
Price Targets

GDRX Price Targets Summary
Goodrx Holdings Inc

Wall Street analysts forecast GDRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GDRX is 6.443 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.

GDRX Lowest Forecast
Wall Street Target
4.04 USD
18% Downside
GDRX Average Forecast
Wall Street Target
6.443 USD
31% Upside
GDRX Highest Forecast
Wall Street Target
9.45 USD
91% Upside
Lowest
Price Target
4.04 USD
18% Downside
Average
Price Target
6.443 USD
31% Upside
Highest
Price Target
9.45 USD
91% Upside
Goodrx Holdings Inc Competitors:
Price Targets
S
SOPH
Sophia Genetics SA
127% Upside
4483
JMDC Inc
27% Upside
HSTM
HealthStream Inc
29% Upside
ALC
Alcidion Group Ltd
10% Upside
S
SOPH
Sophia Genetics SA
127% Upside
4483
JMDC Inc
27% Upside
HSTM
HealthStream Inc
29% Upside
ALC
Alcidion Group Ltd
10% Upside
BMT
Beamtree Holdings Ltd
169% Upside
6095
MedPeer Inc
25% Downside
3902
Medical Data Vision Co Ltd
10% Upside
NXU
Nexus AG
0% Upside

Revenue
Forecast

Revenue Estimate
Goodrx Holdings Inc

For the last 7 years the compound annual growth rate for Goodrx Holdings Inc's revenue is 26%. The projected CAGR for the next 3 years is 6%.

26%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Goodrx Holdings Inc

For the last 7 years the compound annual growth rate for Goodrx Holdings Inc's operating income is 4%. The projected CAGR for the next 3 years is 59%.

4%
Past Growth
59%
Estimated Growth
Estimates Accuracy
-91%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Goodrx Holdings Inc

For the last 7 years the compound annual growth rate for Goodrx Holdings Inc's net income is -8%. The projected CAGR for the next 3 years is 128%.

-8%
Past Growth
128%
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
GDRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
GDRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GDRX stock valuation using valuation multiples.
Wall Street Estimates
GDRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GDRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GDRX's stock price target?
Price Target
6.443 USD

According to Wall Street analysts, the average 1-year price target for GDRX is 6.443 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.

What is Goodrx Holdings Inc's Revenue forecast?
Projected CAGR
6%

For the last 7 years the compound annual growth rate for Goodrx Holdings Inc's revenue is 26%. The projected CAGR for the next 3 years is 6%.

What is Goodrx Holdings Inc's Operating Income forecast?
Projected CAGR
59%

For the last 7 years the compound annual growth rate for Goodrx Holdings Inc's operating income is 4%. The projected CAGR for the next 3 years is 59%.

What is Goodrx Holdings Inc's Net Income forecast?
Projected CAGR
128%

For the last 7 years the compound annual growth rate for Goodrx Holdings Inc's net income is -8%. The projected CAGR for the next 3 years is 128%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.